Financials data is unavailable for this security.
View more
Year on year Eastwood Bio-Medical Canada Inc 's revenues fell -33.22% from 1.30m to 867.94k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 149.88k to a larger loss of 546.60k.
| Gross margin | 61.58% |
|---|---|
| Net profit margin | -74.49% |
| Operating margin | -74.52% |
| Return on assets | -111.39% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in CADView more
In 2023, cash reserves at Eastwood Bio-Medical Canada Inc fell by 21.39k. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 16.89k for operations while cash used for investing totalled .
| Cash flow per share | -0.0055 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.0149 |
|---|---|
| Tangible book value per share | -0.0149 |
More ▼
Balance sheet in CADView more
| Current ratio | 0.0536 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
